Product Reports Resources Pricing Login Book a demo

Occuity

Health Tech & Medtech · Reading, United Kingdom · Founded 2019

Optical Healthcare Monitoring And Screening | Occuity | Reading MoreLess

Occuity is a health technology startup that specializes in the development of medical devices for the screening and monitoring of chronic diseases such as diabetes, Alzheimer's, glaucoma, and myopia. The company's unique approach involves using the eye as a 'window to the health of the body', a concept they refer to as 'Oculomics'.

Occuity's innovative technology is protected by 9 international patents, covering the measurement technique and optical technology that forms the basis of their devices. Additional patents relate to the alignment and measurements within the eye. This intellectual property forms the backbone of their business model, allowing them to create unique, cutting-edge products.

The company's primary market includes high street pharmacies and care homes, where their devices can be used for non-clinical disease screening. This makes the process of detecting chronic diseases easier, cheaper, and safer, potentially revolutionizing the way these conditions are managed.

Occuity's business model is likely based on the sale of their patented devices to these establishments, as well as the potential for ongoing service or maintenance contracts. The company's work presents an exciting opportunity for a significant shift in optometry practice and chronic disease management over the next decade.

Keywords: Health Technology, Medical Devices, Chronic Disease Screening, Oculomics, Patented Technology, Non-Clinical Disease Screening, Diabetes, Alzheimer's, Glaucoma, Myopia.

Company overview

Occuity company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2019
Headquarters
Reading, United Kingdom
Employees
44
Open positions
2
Dealroom signal
80.7
client focusb2bclient focusb2ctechnologyHardwaresub industryMedical DevicessectorDiabetesbusiness modelManufacturingindustryHealthsectorOphthalmologysectorRemote MonitoringsectorAlzheimers DiseasesectorScreeningsectorHealth DiagnosticssectorMetabolismsectorPhysician Support Tools

Valuation & funding

Occuity funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANTOther financing Jul 2026 $2M UK Research and Innovation
EARLY VCEquity / VC Dec 2025 $1.5M $53M Republic Europe
EARLY VCEquity / VC Mar 2025 Remidio
GRANTOther financing Nov 2024 $2.2M UK Research and Innovation
CONVERTIBLEEquity / VC Dec 2023 $1.7M Undisclosed
GRANTOther financing Dec 2022 Undisclosed
GRANTOther financing Aug 2022 Undisclosed
SEEDEquity / VC Oct 2021 Republic Europe
SEEDEquity / VC Oct 2020 Angel Investment Network
SEEDEquity / VC Mar 2020 Business Angels
Showing 10 recorded eventsUnlock the complete deal history →

Financials

Revenue, earnings and profit over time

Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.

YearRevenueGrowthEBITDAMarginProfitMarginR&D
2026 $369K 0% −$2.9M -798.5% −$2.3M -634.4% $15K
2025 $369K +3.2% −$2.9M -798.5% −$2.3M -634.4% $15K
2024 $358K +192.2% −$2.9M -823.9% −$1.9M -544.6% $15K
2023 $122K 0% −$2.9M -2407.7% $15K
2022 $122K 0% −$2.9M -2407.7%
2021 $122K +32.4% −$2.8M -2324.4%
2020 $92K −$950K -1027.9%
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Occuity website traffic

Latest recorded traffic for Occuity is 7K monthly website visits, up 84.2% over the last three months. Occuity's team grew 7.3% over the past year.

Latest monthly visits7K 3-month web change+84.2% 1-year team growth+7.3%
Monthly website visits68 observations · Oct 2020–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Occuity compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Occuity's talent

Book a demo to see the people
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

6 investors on Occuity's cap table

Sourced from Dealroom's funding and investor records.

Seed 4 investors entered at this stage
Business Angels
Angel Investment Network
Republic Europe
UK Research and Innovation
Series A 1 investor entered at this stage
Remidio
Other known 1 additional known investor
LongevityTech.fund

Global footprint

Where Occuity has talent and traffic

Workforce by country
9 countries with
team presence
🇬🇧 United Kingdom73.2%
🇬🇷 Greece4.9%
🇦🇪 United Arab Emirates4.9%
🇺🇸 United States4.9%
🇮🇪 Ireland2.4%
Top 5 of 9 shown

In the news

Latest news about Occuity

Recent press, funding announcements, and product moves mentioning Occuity — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Occuity

An AI-synthesized read of the highest-engagement posts about Occuity on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Occuity’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.